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Abstract  19 
Acinetobacter baumannii has rapidly emerged as a major cause of Gram-negative hospital 20 
infections worldwide. A. baumannii encodes for the transport protein AceI, which confers 21 
resistance to chlorhexidine, a widely-used antiseptic. AceI is also the prototype for the 22 
recently discovered Proteobacterial Antimicrobial Compound Efflux (PACE) family of 23 
transport proteins that confer resistance to a range of antibiotics and antiseptics in many 24 
Gram-negative bacteria, including pathogens. The gene encoding AceI is conserved in the 25 
core genome of A. baumannii, suggesting it has an important primordial function. This was 26 
incongruous with the only characterised substrate of AceI, chlorhexidine, an entirely synthetic 27 
biocide produced only during the last century. Here we investigated a potential primordial 28 
function of AceI and other members of the PACE family in the transport of naturally 29 
occurring polyamines. Polyamines are abundant in living cells, where they have 30 
physiologically important functions and play multifaceted roles in bacterial infection. Gene 31 
expression studies revealed that the aceI gene is induced in A. baumannii by the short chain 32 
diamines cadaverine and putrescine. Membrane transport experiments conducted in whole 33 
cells of A. baumannii and  Escherichia coli, and in proteoliposomes showed that AceI 34 
mediated the efflux of these short chain diamines when energised by an electrochemical 35 
gradient. Assays conducted using eight additional diverse PACE family proteins identified 36 
three that also catalysed cadaverine transport. All together these results demonstrate that short 37 
chain diamines are common substrates for the PACE family of transport proteins, adding to 38 
their broad significance as a novel family of efflux pumps.  39 
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Significance 41 
Multidrug efflux pumps are highly promiscuous determinants of antimicrobial resistance in 42 
bacterial pathogens. Since efflux pumps evolved long before the widespread use of 43 
antimicrobials, drug transport is likely to be a side reaction in many pumps, fortuitously 44 
beneficial to bacteria in hospitals. The AceI efflux protein from Acinetobacter baumannii is 45 
the prototype for the PACE family. AceI was only known to transport the synthetic biocide 46 
chlorhexidine, which was incongruous with its ancient origin. Here we demonstrate that short 47 
chain diamines are the physiological substrates of AceI and other PACE members, and that 48 
transport is energised by an electrochemical gradient of protons. These observations are 49 
important because diamines play vital roles in bacterial physiology and virulence, and have 50 
significant commercial uses. 51 




Multidrug efflux pumps are encoded in all bacterial genomes sequenced to date (1, 2). These 55 
proteins are most studied for their functions in drug resistance. However, multidrug efflux 56 
pumps participate in many additional processes, such as cell adherence, invasion, biofilm 57 
formation, virulence, natural product secretion, and resistance to host encoded factors (3). 58 
This diverse array of functions reflects the promiscuous substrate recognition profiles of 59 
multidrug efflux pumps, which can extend well beyond antibiotics and biocides. Indeed, for 60 
many multidrug efflux pumps the natural physiological substrates are likely to be 61 
endogenously produced small molecules, and the recognition of antimicrobial compounds is a 62 
fortuitous consequence of flexible substrate recognition pockets that can accommodate a 63 
diverse array of chemical structures.  64 
A major goal of this study was to elucidate the physiological function of the AceI efflux 65 
pump, the prototype for the most recently discovered family of multidrug efflux pumps, and 66 
also of its homologues known as the Proteobacterial Antimicrobial Compound Efflux (PACE) 67 
family (4, 5). AceI is encoded by a gene that is highly conserved in the core genome 68 
Acinetobacter baumannii. Prior to this study the only recognised substrate for the AceI efflux 69 
pump was the biocide chlorhexidine. Chlorhexidine is a bisbiguanide compound consisting of 70 
terminal proguanil groups separated by a 1,6-diaminohexane moiety. Chlorhexidine is of 71 
massive importance in pathogen control, it is listed as an “Essential Medicine” by the World 72 
Health Organisation and is used globally in a broad range of antiseptic and disinfectant 73 
preparations. Despite its current importance, chlorhexidine was first synthesised only last 74 
century, so would not have been present in the environment across the evolution of the AceI 75 
pump, and could not have imposed selective pressure for aceI gene maintenance during this 76 
time. 77 
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Some naturally occurring polyamines share structural similarities with chlorhexidine, since 78 
their molecules are comprised of aliphatic carbon chains with interspersed and/or terminal 79 
amino groups that are typically charged at physiological pH (6). Therefore, polyamines were 80 
viewed as candidates for potential physiological substrates of AceI and other PACE pumps. 81 
Polyamines such as cadaverine, putrescine, spermidine and spermine are common in 82 
prokaryotic and eukaryotic cells, where they may exist at high concentrations (mM) and have 83 
varied vital functions in protein and nucleic acid stability, metabolism, nitrogen storage, acid 84 
tolerance, cell to cell communication, motility, transcriptional regulation and protein 85 
expression (7, 8). These biologically abundant polyamines also function in host immune 86 
responses and bacterial virulence (8). 87 
A number of different transport systems that promote the uptake of polyamines into bacteria 88 
have been characterised (9). These uptake systems may help to support the high cellular 89 
requirements for polyamines and facilitate catabolism of exogenous polyamines [9]. Despite 90 
their high abundance and broad physiological significance, polyamines ca  inhibit cell growth 91 
when they are in excess, requiring cells to have detoxification mechanisms. Efflux pumps that 92 
transport polyamines out of the cell have also been identified (10, 11). Active polyamine 93 
efflux systems could help to maintain cellular concentrations of polyamines at sub-toxic 94 
levels, and may also be required to export polyamines involved in cellular communication or 95 
bacterial motility. Bacterial multidrug efflux pumps from the small multidrug resistance 96 
(SMR; e.g., MdtIJ in Escherichia coli) family and the major facilitator superfamily (MFS; 97 
e.g., Blt from Bacillus subtilis) have previously been shown to mediate polyamine efflux (10, 98 
11). In this study, we examined polyamines as potential physiological substrates of the 99 
prototypical PACE family member, AceI from Acinetobacter baumannii (4), and some of its 100 
homologues. 101 
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Active efflux pumps need to capture the energy required to move their primary substrate 102 
against its concentration gradient out of the cell. In previously characterised families of drug 103 
efflux proteins, the energy is provided by a secondary substrate such as ATP, which provides 104 
chemical energy during hydrolysis to ADP, or a transmembrane electrochemical gradient of 105 
monovalent cations (typically H+ or Na+, and occasionally K+) that are exchanged for primary 106 
substrates in antiport reactions (12). AceI and other PACE family proteins do not include 107 
nucleotide binding domains that are typically associated with ATP-driven pumps and are not 108 
encoded in proximity to, or coordinately regulated with, genes encoding these domains in 109 
bacterial genomes. Therefore, it was likely that PACE proteins energised the transport of their 110 
primary substrates using an electrochemical gradient, which we now show is the proton-111 
motive-force. In addition, we determine the specificities of induction and transport for 112 
polyamines using both intact cells and liposomes containing isolated AceI.  113 
  114 
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Results and Discussion 115 
Expression of the aceI efflux pump gene i  A. baumannii is induced by polyamines 116 
We conducted qRT-PCR to determine whether the addition of exogenous polyamines would 117 
elicit a transcriptional response in aceI gene expression in Acinetobacter baumannii. The cells 118 
were treated with four polyamines including the short chain diamines cadaverine and 119 
putrescine, the tri-amine spermidine, and the tetra-amine spermine. These polyamines were 120 
chosen for analysis since they represent the major groups of polyamines found in most 121 
organisms (8). We found that both of the diamines caused strong induction of aceI gene 122 
expression, around 20-fold higher than in untreated cells (Figure 1A). In contrast, aceI 123 
expression was only moderately induced by spermidine (5.2-fold induction) and weakly 124 
induced by spermine (2.8-fold induction). The initial discovery of the AceI pump was based 125 
on upregulation of aceI by chlorhexidine (4). In these investigations chlorhexidine caused an 126 
approximately ten-fold increase in aceI expression in A. baumannii ATCC 17978 (4).  127 
aceI is required for A. baumannii to tolerate exogenous diamines 128 
The induction of aceI by the addition of cadaverine or putrescine, and to a lesser extent 129 
spermidine and spermine, suggested that these compounds may be substrates of the AceI 130 
efflux pump. Since these polyamines have some level of toxicity towards many species of 131 
bacteria, we tested this possibility by examining the requirement of the aceI gene for 132 
polyamine tolerance in A. baumannii. Minimum inhibitory concentration analyses were 133 
conducted to test tolerance to putrescine, cadaverine, spermidine and spermine, in wild-type 134 
A. baumannii AB5075-UW, and in an isogenic aceI-inactivated mutant strain (13). The 135 
parental strain tolerated high concentrations of all four polyamines; the minimum inhibitory 136 
concentrations were 40 g/ml in the case of putrescine, cadaverine and spermidine, and 10 137 
g/ml for spermine (SI Appendix, Fig. S1). Inactivation of aceI in AB5075-UW resulted in at 138 
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least eight-fold reductions in tolerance to cadaverine and putrescine, but no change in 139 
tolerance to spermidine or spermine (SI Appendix, Fig. S1). This suggested that AceI may 140 
recognise diamines as substrates, but that it does not recognise tri- or tetra-amines, or does so 141 
only weakly. The minimum inhibitory concentration of chlorhexidine for A. baumannii is 142 
more than 1000-fold lower than that of cadaverine or putrescine, but inactivation of aceI in A. 143 
baumannii causes only a two-fold reduction in chlorhexidine tolerance (14). The high fold-144 
reductions in tolerance after aceI inactivation observed for cadaverine and putrescine suggest 145 
efflux of short chain diamines may be a primary role of AceI. 146 
Expression of the AceI protein Acinetobacter baumannii or  Escherichia coli reduces the 147 
accumulation of cadaverine  148 
To test whether the reduced tolerance to diamines in the aceI mutant A. baumannii strain was 149 
related directly to the efflux of these compounds, we examined accumulation of [14C]-labelled 150 
cadaverine into mutant cells compared to the parental strain. The parental AB5075-UW strain 151 
accumulated minimal amounts of [14C]-cadaverine when it was added to the media (Fig. 1B). 152 
In contrast, the aceI inactivated mutant readily accumulated [14C]-cadaverine, suggesting that 153 
normal levels of AceI induced by cadaverine in Acinetobacter baumannii prevent high 154 
accumulation of the diamine into the cells, consistent with cadaverine efflux activity. 155 
Laboratory E. coli strains are excellent hosts for studies examining the function of PACE 156 
family proteins because they do not carry genes encoding endogenous PACE family proteins 157 
that could interfere with the activity of heterologously expressed proteins; indeed PACE 158 
family genes have been found in less than 0.2 % of sequenced E. coli genomes and never in 159 
laboratory strains (4, 15). To confirm that  AceI isolated from A. baumannii does mediate the 160 
efflux of short chain diamines, we examined the level of [14C]-cadaverine accumulation in E.161 
coli cells expressing AceI compared to cells expressing an inactive AceI mutant harbouring 162 
an E15Q substitution (AceI-E15Q) and to control cells carrying the empty vector expression 163 
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plasmid (Fig. 1C). Importantly, immunoblot analyses demonstrated that both AceI and AceI-164 
E15Q were expressed at similar levels in the induced cells (SI Appendix, Fig. S2). [14C]-165 
Cadaverine was readily accumulated in both the empty vector control cells and the cells 166 
expressing the AceI-E15Q mutant protein. In contrast, the concentration of [14C]-cadaverine 167 
in E. coli cells expressing the parental AceI protein did not significantly increase over the 168 
time course of the experiment (Fig. 1C), suggesting that AceI can transport cadaverine out of 169 
the cell at a rate equal to or higher than its rate of accumulation. The AceI-E15Q protein was 170 
previously shown to be incapable of mediating chlorhexidine resistance or transport (4). Since 171 
cells expressing this mutant accumulated [14C]-cadaverine to a similar level as the negative 172 
control (Fig. 1C) it appears that an acidic residue at position 15 is necessary for all transport 173 
activity of AceI.  174 
The AceI protein promotes the transport of [14C]-cadaverine in a reconstituted system 175 
Previous attempts to obtain measurements of AceI mediated transport of chlorhexidine in a 176 
reconstituted system were not successful (4). At that ime, chlorhexidine was the only 177 
recognised substrate for the protein, and chlorhexidine is very poorly suited to experiments 178 
using proteoliposomes. Specifically, chlorhexidine is poorly soluble, it adsorbs non-179 
specifically to most filter membranes and to biological membranes, and it is a membrane 180 
active biocide, so even low concentrations tend to disrupt naked proteoliposomes. The 181 
identification of cadaverine and putrescine as potential substrates of the AceI transport system 182 
in this study presented a new opportunity to examine the activities of AceI in a reconstituted 183 
membrane bilayer system. 184 
Both the wild-type AceI protein and the inactive AceI-E15Q mutant protein were purified and 185 
reconstituted into preformed liposomes composed of E. coli polar lipids (SI Appendix, 186 
Methods). For comparison empty liposomes were also generated using the same approach. An 187 
experimental system was established to generate an electrochemical gradient across the 188 
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(proteo)liposome membranes, consisting of both a chemical proton gradient (pH; inside 189 
acidic) and an electrical potential (; inside positive) (Fig. 2A). The lumen of the 190 
(proteo)liposomes contained Na+ at pH 7.0. The (proteo)liposomes were diluted into a buffer 191 
containing isosmolar K+ and a low concentration of the potassium ionophore valinomycin at 192 
pH 8.0. The difference in pH of the buffers generated pH, and the valinomycin promoted the 193 
downhill movement of K+ into the (proteo)liposomes, generating  inside positive (Fig. 2A) 194 
(16, 17). The polarity of the pH and charge differential (inside positive and acidic) across the 195 
membrane could energise the uptake of externally applied substrates in exchange for a cation, 196 
such as a proton, by any active antiport system (16), in this case AceI (Fig. 2A). 197 
There was some uptake of cadaverine into liposomes without incorporated protein (Fig. 2B), 198 
which was probably the result of uncharged cadaverine diffusing across the membrane and 199 
accumulating in the lumen by protonation. The proteoliposomes containing wild-type AceI 200 
and energised by an electrical and pH gradient positive and acidic inside accumulated [14C]-201 
cadaverine (Fig. 2B) much more rapidly. After subtraction of the small amount of 202 
accumulation in liposomes the initial rate of cadaverine uptake between the first and second 203 
assay time points (30 and 120 sec) was 16.7±5.9 nmol/mg protein/min (SI Appendix, Fig. 204 
S3). In contrast, the rate of [14C]-cadaverine uptake into proteoliposomes containing the 205 
inactive AceI-E15Q mutant was indistinguishable from the rate into liposomes without any 206 
incorporated protein, calculated to be -0.2 0.7 nmol/mg protein/min between the first and 207 
second time points (Fig. 2B and S3). AceI proteoliposomes that were not treated with 208 
valinomycin, and thus had pH (inside acidic) but no , accumulated [14C]-cadaverine at a 209 
much lower rate of 3.93.7 nmol/mg protein/min between the first and second assay time 210 
points (Fig. 2B and S3, SI Appendix, Table S1). AceI proteoliposomes were also diluted into 211 
the same buffer without valinomycin, but with the protonophore CCCP that discharges both 212 
electrical and pH gradients. In this case, the proteoliposomes still took up [14C]-cadaverine, 213 
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but at a much slower rate of 3.1 2.0 nmol/mg protein/min between the first and second assay 214 
time points (Fig. 2B and S3, SI Appendix, Table S1) a reduction of about 80% in activity 215 
from the energised rate. Based on these results and those described below, energised AceI-216 
mediated cadaverine transport appears to be driven by proton exchange. The intermediate 217 
levels of [14C]-cadaverine accumulation seen in the absence of valinomycin or presence of 218 
CCCP, which were above that seen in the liposome negative control, may be driven by the 219 
unenergized downhill movement of [14C]-cadaverine into the proteoliposomes facilitated by 220 
AceI, i.e. a relatively low level of ‘uniport’ (facilitated diffusion) activity, which might even 221 
reflect a variable stoichiometry of cadaverine:H+, as seen in other secondary transporters (18). 222 
Also, low level transport may be driven by an alternative coupling ion, such as Na+, which is 223 
present in the lumen of the proteoliposomes.  224 
Overall, the rapid non-linear accumulation of [14C]-cadaverine into the reconstituted 225 
proteoliposomes fully energised by both   and pH, markedly above the levels seen in the 226 
control and uncoupled experiments, demonstrated that AceI can promote the active transport 227 
of cadaverine in exchange for a cation.   228 
 [14C]-cadaverine uptake into AceI proteoliposomes is inhibited by putrescine 229 
With a reconstituted AceI transport assay system in place for [14C]-cadaverine it was possible 230 
to assess whether AceI can recognise alternative substrates by examining competitive 231 
inhibition of [14C]-cadaverine transport. Since putrescine and spermidine induced measurable 232 
increases in expression of the aceI gene (Fig. 1A), we tested whether unlabelled putrescine or 233 
spermidine reduced [14C]-cadaverine uptake into AceI proteoliposomes at 50-fold (1 mM) and 234 
500-fold (10 mM) molar excess over [14C]-cadaverine. Putrescine caused significant 235 
inhibition of [14C]-cadaverine uptake into AceI proteoliposomes, 43.9 % inhibition of uptake 236 
by 1 mM putrescine and 85.9 % inhibition by 10 mM putrescine, equivalent to the addition of 237 
excess unlabelled cadaverine (Fig. 2C). In contrast, spermidine caused only a marginal level 238 
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of inhibition of [14C]-cadaverine uptake; 1 mM spermidine caused 15.7 % inhibition and 10 239 
mM spermidine caused 31.0 % inhibition (Fig. 2C). These results suggest that putrescine can 240 
be transported by AceI at an equivalent rate to cadaverine, but that spermidine is poorly 241 
recognised by AceI, consistent with the results of the polyamine tolerance experiments (SI 242 
Appendix, Fig. S1), where inactivation of aceI in A. baumannii caused a reduction in 243 
tolerance to both putrescine and cadaverine, but not to spermidine. Therefore, of the 244 
polyamines tested, AceI appears to recognise specifically the short chain diamines, cadaverine 245 
and putrescine as substrates. 246 
AceI-mediated cadaverine and putrescine transport into proteoliposomes occurs in parallel 247 
with internal pH changes 248 
The results described above provided good evidence for AceI being a secondary active 249 
transport protein for cadaverine and putrescine, i.e., the reconstituted transport experiments 250 
showed that the generation of an inside positive electrical potential significantly increased the 251 
rate of uptake of externally applied [14C]-cadaverine into AceI proteoliposomes (Fig. 2). This 252 
suggested that AceI may catalyse a diamine:cation antiport reaction. To help confirm whether 253 
the cation was a proton we examined pH changes inside the lumen of AceI proteoliposomes 254 
during transport of diamine achieved by using a membrane impermeable pH sensitive 255 
fluorescent dye, 8-hydroxypyrene-1,3,6-trisulfonic acid (pyranine, see SI Appendix, 256 
Methods). 257 
Experimental conditions were established to generate a proton electrochemical gradient 258 
(inside acidic and positive), described above using [14C]-cadaverine for the assay of AceI 259 
transport activity in the reconstituted system. Proteoliposomes containing AceI or the AceI-260 
E15Q mutant, and empty control liposomes were formed in Na+ buffer at pH 7.0. To establish 261 
a pH gradient in the assay the (proteo)liposomes were diluted into buffer at higher pH (pH 262 
8.0). An electrical gradient, , was generated by the inclusion of isosmolar K+ in the 263 
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external assay buffer and the subsequent addition of 5 nM valinomycin to catalyse the 264 
downhill movement of K+ into the lumen of the proteoliposomes (Fig. 3A). The addition of 265 
valinomycin caused a slow increase in the F509 (ex. 450 nm)/ F509 (ex. 400 nm) fluorescence 266 
ratio of the AceI proteoliposomes and empty liposomes, consistent with a gradual increase in 267 
the luminal pH likely due to the leakage of protons down their electrical gradient out of the 268 
(proteo)liposomes (Fig. 3A). The addition of 1 mM cadaverine to the energised AceI 269 
proteoliposomes resulted in a far more rapid alkalisation of the proteoliposome lumen, 270 
observed through a rapid increase in the F509 (ex. 450 nm)/ F509 (ex. 400 nm) fluorescence 271 
ratio of pyranine (Fig. 3A). In contrast, there was no significant change in the internal pH in 272 
empty liposomes or proteoliposomes containing AceI-E15Q after cadaverine addition (Fig. 273 
3A). This result suggested that AceI catalyses the exchange of protons for cadaverine, i.e., the 274 
luminal pH increases as protons are exported in exchange for cadaverine. The level of 275 
fluorescence change induced by different concentrations of cadaverine (0-10 mM) in this 276 
assay system was examined to determine whether the rate of pH change could be saturated. 277 
The results indicated that the rate of fluorescence change was saturable (Fig. 3B) consistent 278 
with the operation of a protein-catalysed active transport activity specific for cadaverine. A 279 
Michaelis-Menten curve fit suggested a Km of 2.65±0.52 mM (Fig. 3B). 280 
We next determined the effect of excluding valinomycin from the assay until after cadaverine 281 
addition to determine whether pH alone could promote AceI-mediated cadaverine transport. 282 
Proteoliposomes containing AceI or the AceI-E15Q mutant, and empty control liposomes 283 
were formed in buffer containing Na+ t pH 7.0, then diluted into isosmolar K+ buffer at pH 284 
8.0. Valinomycin was initially omitted and 1 mM cadaverine was added; this induced a pH 285 
change in the lumen of AceI proteoliposomes that was above the background level seen in the 286 
liposome control or in proteoliposomes containing AceI-E15Q (Fig. 3C). However, the 287 
fluorescence change was well below that seen when cadaverine was added to AceI 288 
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proteoliposomes after the generation of an electrical potential by valinomycin (Fig. 3A). 289 
Subsequent addition of valinomycin to the AceI proteoliposomes, thus generating an inside 290 
positive electrical potential, again resulted in a very rapid increase in the internal pH, well 291 
above that seen in the liposome control or in proteoliposomes containing AceI-E15Q (Fig. 292 
3C). Similar to the reconstituted transport experiments using [14C]-cadaverine, these results 293 
suggest that an electrical gradient, , can promote rapid AceI-mediated cadaverine transport.  294 
To examine the effect of  in the absence of pH on AceI activity in this system, 295 
proteoliposomes containing AceI or the AceI-E15Q mutant, and empty control liposomes, 296 
were formed in buffer containing Na+ t pH 7.0, then diluted into isosmolar K+ buffer at pH 297 
7.0. Valinomycin was added to generate an electrical potential, followed by cadaverine. In 298 
this system 1 mM cadaverine did not induce a significant change in pH in the interior of AceI 299 
proteoliposomes or in control liposomes that was reliably detectable using the pyranine 300 
indicator. However, increasing the concentration of cadaverine to 100 mM resulted in a large 301 
pH change inside the AceI proteoliposomes that was similar in amplitude to that seen after 1 302 
mM cadaverine addition at pH 8.0 with valinomycin energisation (Fig. 3A and 3D). No 303 
significant change in pH was observed in the control liposomes or AceI-E15Q 304 
proteoliposomes after addition of 100 mM cadaverine under these conditions, showing that 305 
the effect was mediated by AceI (Fig. 3D) and not by the change in osmolarity across the 306 
liposome membrane. We also examined the effect of putrescine and spermidine addition to 307 
AceI proteoliposomes in this experimental system. The addition of 100 mM putrescine 308 
induced a significant pH change in AceI proteoliposomes, but spermidine did not (SI 309 
Appendix, Fig. S4). However, we did observe some precipitation of spermidine or buffer 310 
components upon its addition. These results are consistent with our observations that aceI 311 
promoted putrescine but not spermidine tolerance in A. baumannii (SI Appendix, Fig. S1), 312 
and that putrescine but not spermidine was able significantly to inhibit AceI-mediated [14C]-313 
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cadaverine transport into proteoliposomes (Fig. 2C). The results provide additional support 314 
that AceI can transport putrescine and cadaverine well, but spermidine poorly, at best.  315 
The reason that a higher concentration of cadaverine was needed to induce a strong pH 316 
change in the  assay system at pH 7.0 may be the result of the chemical properties of 317 
cadaverine and the nature of electrochemically driven transport reactions. Cadaverine has two 318 
amines with pKas of 10.25 and 9.13 (6). Consequently, the majority of the cadaverine added 319 
at neutral pH will be protonated and thus charged at both amines. Transport reactions driven 320 
by an electrical gradient alone must be electrogenic themselves (17). Therefore, if AceI 321 
mediates the exchange of cadaverine for protons driven by the electrical potential, the number 322 
of protons exchanged must increase with the charge state of cadaverine, i.e., one or more 323 
protons exchanged for the neutral form of cadaverine, two or more for a singly charged form 324 
and three or more for cadaverine charged at both amines. This may favour the transport of 325 
neutrally charged cadaverine. Since cadaverine has two ionisable groups with high pKas, at 326 
pH 7.0 the concentration of neutral compound would be approximately 100 times lower than 327 
at pH 8.0, since for each amine group there will be an approximately ten-fold increase in the 328 
non-protonated form for each 1 pH unit increase. This may be why a 100-fold increase in 329 
cadaverine concentration was required at pH 7.0 (Fig. 3D) to promote a pH change similar to 330 
that seen at pH 8.0 (Fig. 3A). If transport of fully neutral or monocationic forms of cadaverine 331 
is favoured by AceI under these experimental conditions, the alkalisation of the 332 
proteoliposome lumen may be at least partly related to the proton accepting potential of the 333 
deprotonated amines, i.e., protons may be accepted by the cadaverine accumulating within the 334 
proteoliposome, so increasing the internal pH. Therefore, it is not possible to conclude with 335 
complete certainty that protons, rather than an alternative cation, such as Na+ ions are 336 
exchanged for substrates by AceI. 337 
pH changes induced in AceI proteoliposomes by chlorhexidine 338 
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Chlorhexidine was the first substrate identified for AceI and is one of the most important 339 
biocides used in healthcare worldwide. As stated above, chlorhexidine is a membrane active 340 
biocide and our previous attempts to examine AceI-mediated transport in a reconstituted 341 
system were not successful, due to non-specific adsorption to filters and biological 342 
membranes, and potential lysis of proteoliposomes by chlorhexidine. The nature of the assays 343 
using pyranine-containing proteoliposomes alleviate the problems of adsorption to filters and 344 
biological membranes, since they do not require the proteoliposomes to be filtered, nor the 345 
total substrate associated with the proteoliposomes to be measured. Therefore, considering 346 
our success in developing this assay system to demonstrate AceI-mediated transport of 347 
cadaverine and putrescine, we attempted assays using chlorhexidine. An experimental system 348 
was employed to generate a pH gradient; (proteo)liposomes were formed in K+ buffer at pH 349 
7.0 and diluted into K+ buffer at pH 8.0. The addition of 100 M chlorhexidine to AceI 350 
proteoliposomes caused alkalisation of the AceI proteoliposome lumen, observed as an 351 
increase in pyranine fluorescence (450 nm excitation/509 nm emission; SI Appendix, Fig. 352 
S5). Addition of the same concentration of chlorhexidine to empty control liposomes caused a 353 
lower level of alkalisation [Note that the addition of an equivalent amount of DMSO, the 354 
solvent for chlorhexidine, to AceI proteoliposomes did not cause a change in the internal pH 355 
(SI Appendix, Fig. S5)]. These observations are consistent with AceI-mediated 356 
chlorhexidine:H+ exchange, but must be viewed with caution, since the chlorhexidine may 357 
have damaged the naked (proteo)liposomes. 358 
Expression of several other PACE family proteins in Escherichia coli reduces cadaverine 359 
accumulation  360 
The results described above focused only on the AceI transport protein as the prototypical 361 
representative of the PACE family. To examine whether other members of the PACE family 362 
can catalyse the transport of cadaverine, we examined the level of [14C]-cadaverine 363 
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accumulation in E. coli cells expressing eight additional PACE family proteins, Fbal_3166 364 
from Ferrimonas balearica, PFL_4558 from Pseudomonas protegens, Pf-5, 655492601 365 
(GenBank protein ID) from Tepidiphilus margaritifer, A1S_1503 from Acinetobacter 366 
baumannii, Mlut_15630 from Micrococcus luteus, PSPTO_3587 from Pseudomonas syringae 367 
pv. tomato str., STY3166 from Salmonella enterica subsp. enterica serovar Typhi str. and 368 
VP1155 from Vibrio parahaemolyticus RIMD 2210633 (SI Appendix, Fig. S6)  Each of these 369 
proteins was produced at readily detectable levels in E. coli BL21 cells upon IPTG induction 370 
(SI Appendix, Fig. S7). Of the additional proteins examined, three prevented the 371 
accumulation of [14C]-cadaverine into E. coli, similar to AceI (SI Appendix, Fig. S6). These 372 
results indicate that cadaverine, and possibly other short chain diamines, are the likely 373 
physiological substrates of many PACE family proteins. 374 
  375 
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Conclusions 376 
The PACE family is the most recently discovered family of multidrug efflux proteins (5). The 377 
genes encoding PACE proteins are conserved in a range of opportunistic Gram-negative 378 
pathogens and may contribute to serious outbreaks of drug resistant infections in hospitals. 379 
Owing to the recency of their identification, their physiological substrates and mechanisms of 380 
transport energisation were unknown. In this study, we made several major advances in 381 
understanding the function of the prototypical PACE family protein, AceI from A. baumannii. 382 
Firstly, polyamines, specifically the short chain primary diamines cadaverine and putrescine, 383 
are strong inducers of aceI in A. baumannii (Fig. 1A). Secondly, cadaverine and putrescine 384 
are substrates of AceI, whereas the longer polyamine, spermidine is o ly a weak substrate of 385 
AceI, even though it induced aceI expression, albeit at a lower level than the equivalent 386 
concentrations of cadaverine and putrescine (Fig. 1A) Thirdly, transport of cadaverine was 387 
effected by AceI protein reconstituted into liposomes. Finally, the trans-membrane electrical 388 
gradient of protons is the primary source of energy for AceI-mediated cadaverine transport, 389 
and the pH gradient may make a contribution. 390 
Polyamines are produced in all cells and have a raft of functions in cellular regulation, 391 
maintaining stability of nucleic acids and proteins, motility and cell to cell signalling (3). 392 
Furthermore, polyamines have multifaceted roles in bacterial virulence and in host immune 393 
responses (8). Many of these effects are likely to be mediated by transport proteins, such as 394 
AceI, that catalyse the efflux or uptake of polyamines. Indeed, activating or deactivating 395 
expression of polyamine transport proteins in various bacteria attenuated virulence (8, 19).396 
Therefore, compounds that modulate polyamine transport systems may have potential to be 397 
used as virulence attenuating drugs. The design of such drugs will now be facilitated by the 398 
knowledge that the physiological substrates are short chain polyamines. In addition to 399 
functions in human health, diamines including cadaverine and putrescine examined in this 400 
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study, have a range of industrial uses especially as precursors of polymers related to nylon 401 
(20). The discovery that AceI is a novel secondary transport system for these compounds adds 402 
potential for developing new biological platforms for their large scale biotechnological 403 
production based around AceI-mediated efflux, which would provide much needed “green” 404 
alternatives to petroleum-based precursors currently produced (20). 405 
  406 
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Methods  407 
A detailed description of all experimental procedures is provided in the SI Appendix, 408 
Methods section. Briefly, for quantitative real-time PCR analyses of aceI gene expression we 409 
followed methods described previously (4, 21). For polyamine tolerance tests we used strains 410 
from the Manoil laboratory collection (13), and a broth microdilution method (22). [14C]-411 
cadaverine dihydrochloride was obtained from American Radiolabelled Chemicals. Whole 412 
cell [14C]-cadaverine accumulation assays were performed following routine methods (4). The 413 
reconstitution method used for AceI and AceI-E15Q proteins was developed from that used 414 
by Ramos Aires and Nikaido (2005) (23). The approaches for generating proton 415 
electrochemical gradients across the proteoliposome membranes are described in the Results 416 
and Discussion, and in detail in the SI Appendix, Methods section. 417 
 418 




We thank Professor Lars Jeuken for helpful discussions about the measurement of pyranine 422 
fluorescence in reconstituted transport experiments. This project was supported by Project 423 
Grants from the National Health and Medical Research Council of Australia to ITP, KAH and 424 
PJFH (GNT1060895 and GNT1120298), an Australian Research Council Future Fellowship 425 
to KAH (FT180100123), a Marie Skłodowska-Curie Research Fellowship from the European 426 
Commission to KAH and PJFH (706499) and an Emeritus Fellowship to PJFH from the 427 
Leverhulme Trust (EM-2014-045). PJFH thanks John H Henderson, Katherine F Henderson, 428 
Mary E Henderson and Helen F Long for their dedicated support. 429 
 430 
Author contributions 431 
KAH, PJFH and ITP conceived the research. KAH, JRE, KAM  LF, SMJ, IA and DS 432 
performed the biochemical experiments and protein purifications. KAH, VN, KAM  QL and 433 
LL performed microbiological experiments. KAH, PJFH and ITP analysed the data and wrote 434 
the manuscript, with all authors contributing to the final version. 435 
  436 
 22 
References 437 
1. Q. Ren, I.T. Paulsen, Large-scale comparative genomic analyses of cytoplasmic 438 
membrane transport systems in prokaryotes. J. Mol. Microbiol. Biotechnol. 439 
12:165-179 (2007). 440 
2. L.D. Elbourne, S.G. Tetu, K.A. Hassan, I.T. Paulsen, TransportDB 2.0: a database for 441 
exploring membrane transporters in sequenced genomes from all domains of life. 442 
Nucleic Acids Res. 45:D320-D324 (2017). 443 
3. L.J. Piddock, Multidrug-resistance efflux pumps - not just for resistance. Nat. Rev. 444 
Microbiol. 4:629-636 (2006). 445 
4. K.A. Hassan, et al., Transcriptomic and biochemical analyses identify a family of 446 
chlorhexidine efflux proteins. Proc. Natl. Acad. Sci. U.S.A. 110:20254-20259 447 
(2013). 448 
5. K.A. Hassan, Q. Li, P.J.F. Henderson, I.T. Paulsen, Homologs of the Acinetobacter 449 
baumannii AceI transporter represent a new family of bacterial multidrug efflux 450 
systems. mBio 6:e01982-01914 (2015). 451 
6. I.S. Blagbrough, A.A. Metwally, A.J. Geall, Measurement of polyamine pKa values. 452 
Methods Mol. Biol. 720:493-503 (2011). 453 
7. K. Igarashi & K. Kashiwagi, Modulation of cellular function by polyamines. Int J 454 
Biochem Cell Biol 42:39-51 (2010). 455 
8. P. Shah, E. Swiatlo, A multifaceted role for polyamines in bacterial pathogens. Mol. 456 
Microbiol. 68:4-16 (2008). 457 
9. K. Igarashi & K. Kashiwagi, Polyamine transport in Escherichia coli. Amino Acids 458 
10:83-97 (1996). 459 
 23 
10. K. Higashi, et al., Identification of a spermidine excretion protein complex (MdtJI) 460 
in Escherichia coli. J Bacteriol 190:872-878 (2008). 461 
11. D.P. Woolridge, et al., Efflux of the natural polyamine spermidine facilitated by 462 
the Bacillus subtilis multidrug transporter Blt. J. Biol. Chem. 272:8864-8866 463 
(1997). 464 
12. I.T. Paulsen, M.H. Brown, R.A. Skurray, Proton-dependent multidrug efflux 465 
systems. Microbiol. Rev. 60:575-608 (1996). 466 
13. L.A. Gallagher, et al., Resources for Genetic and Genomic Analysis of Emerging 467 
Pathogen Acinetobacter baumannii. J. Bacteriol. 197:2027-2035 (2015). 468 
14. A.T. Tucker, et al., Defining gene-phenotype relationships in Acinetobacter 469 
baumannii through one-step chromosomal gene inactivation. MBio 5:e01313-470 
01314 (2014). 471 
15. K.A. Hassan, et al., An ace up their sleeve: a transcriptomic approach exposes the 472 
AceI efflux protein of Acinetobacter baumannii and reveals the drug efflux 473 
potential hidden in many microbial pathogens. Front. Microbiol. 6:333 (2015). 474 
16. P.J.F. Henderson, J.D. McGivan, J.B. Chappell, The action of certain antibiotics on 475 
mitochondrial, erythrocyte and artificial phospholipid membranes. The role of 476 
induced proton permeability. Biochem. J. 111:521-535 (1969). 477 
17. P.J.F. Henderson, Ion transport by energy-conserving biological membranes. 478 
Annu. Rev. Microbiol. 25:393-428 (1971). 479 
18. A. Bazzone, A.J. Zabadne, A. Salisowski, M.G. Madej, K. Fendler, A loose 480 
relationship: incomplete H+/sugar coupling in the MFS sugar transporter GlcP. 481 
Biophysical J. 113:2736Ȃ2749 (2017). 482 
 24 
19. A.N. Rai, et al., Polyamine transporter in Streptococcus pneumoniae is essential for 483 
evading early innate immune responses in pneumococcal pneumonia. Sci. Rep. 484 
6:26964 (2016). 485 
20. W.C. Ma, et al., Advances in Cadaverine Bacterial Production and Its Applications. 486 
Engineering 3:308-317 (2017). 487 
21. A.J. Brzoska, K.A. Hassan, Quantitative PCR for detection of mRNA and gDNA in 488 
environmental isolates. Methods Mol. Biol., Environmental Microbiology, 2nd 489 
Edition, I.T. Paulsen, A. Holmes Eds (Humana Press, 2014), pp 25-42. 490 
22. I. Wiegand, K. Hilpert, R.E. Hancock, Agar and broth dilution methods to 491 
determine the minimal inhibitory concentration (MIC) of antimicrobial 492 
substances. Nat. Protoc. 3:163-175 (2008). 493 
23. J.R. Aires, H. Nikaido, Aminoglycosides are captured from both periplasm and 494 
cytoplasm by the AcrD multidrug efflux transporter of Escherichia coli. J. 495 
Bacteriol. 187:1923-1929 (2005). 496 
497 
 25 
Figure legends. 498 
Figure 1. (A) Induction of aceI gene expression by polyamines. Polyamines were added to the 499 
A. baumannii AB5075-UW media when the cells were in mid-exponential growth phase (SI 500 
Appendix, Methods). The bars represent the change in aceI gene expression compared to an 501 
untreated control after 30 mins growth in the presence of the polyamines. Error bars show the 502 
standard deviations of at least two biological and four technical replicates. (B) Accumulation 503 
of [14C]-cadaverine into A. baumannii wild-type (AB5075-UW) or an aceI inactivated mutant 504 
(aceI) (13). The cells were exposed to a low concentration of cadaverine for 30 mins to 505 
allow aceI expression, then washed and incubated with 50 M [14C]-cadaverine using 1 % 506 
succinate provided as an energy source. Each sample included 100 L of cells at OD600 = 1.0 507 
(SI Appendix, Methods). (C) Accumulation of [14C]-cadaverine into E. coli BL21 cells 508 
overexpressing the wild-type AceI protein (AceI), the inactive E15Q AceI mutant protein 509 
(E15Q) or no additional protein (Negative). In these E. coli cells, expression of aceI or its 510 
E15Q variant was induced by IPTG and the harvested, washed cells were incubated with 50 511 
M [14C]-cadaverine with 1% glucose provided as an energy source. Each sample included 512 
100 L of cells at OD600 = 1.0  (SI Appendix, Methods). Error bars show the standard 513 
deviation of at least three independent replicate experiments.  514 
Figure 2. Uptakes of [14C]-cadaverine into (proteo)liposomes. (A) Schematic representation of 515 
the strategy used for generating a proton electrochemical gradient ( ҧߤ H+) across the 516 
proteoliposome membrane. (Proteo)liposomes were formed in Na+-containing buffer at pH 517 
7.0, then diluted into K+ buffer at pH 8.0 containing the K+ ionophore valinomycin.   (B) 518 
Liposomes and proteoliposomes containing AceI or AceI-E15Q were formed (SI Appendix, 519 
Methods) and treated as shown in panel A. The results show [14C]-cadaverine uptake per 520 
fraction. Uptake of [14C]-cadaverine was faster in energised AceI proteoliposomes (blue line) 521 
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compared to empty liposomes (green line) or proteoliposomes containing the inactive AceI-522 
E15Q protein (tan line). [14C]-cadaverine uptake into AceI proteoliposomes without 523 
valinomycin, or with the addition of CCCP occurred at an intermediate rate (purple and red 524 
lines, respectively). (C) Inhibition of AceI mediated [14C]-cadaverine transport by alternative 525 
AceI substrates. Transport experiments were performed as for the blue trace in panel B, but in 526 
the presence of 1 or 10 mM unlabelled cadaverine, putrescine or spermidine. The values 527 
shown are the amount of [14C]-cadaverine accumulated after ten minutes as a percentage of 528 
the amount accumulated with no inhibitor.  Error bars show the standard deviations of at least 529 
three independent replicate experiments. 530 
Figure 3. Cadaverine-induced pH changes inside proteoliposomes containing AceI. 531 
Proteoliposomes were formed in buffer containing the pH sensitive fluorescent dye pyranine 532 
(SI Appendix, Methods). The excitation maximum of pyranine shifts from 400 nm to 450 nm 533 
with increasing in pH, whereas the emission maximum is stable at approximately 509 nm. 534 
Plots A, C and D show the 450:400 nm fluorescence (509 nm) excitation ratio of pyranine in 535 
the lumen as follows: control liposomes without added protein (green); proteoliposomes 536 
containing the inactive AceI-E15Q mutant protein (tan); and proteoliposomes containing 537 
wild-type AceI (blue). An increase in this ratio is indicative of an increase in internal pH. All 538 
(proteo)liposomes were formed in Na+ buffer at pH 7.0 (SI Appendix, Methods). (A) 539 
(Proteo)liposomes were diluted into K+ buffer at pH 8.0, 5 nM valinomycin (val) was added 540 
at the first arrow and 1 mM cadaverine was added at the second arrow. (B) AceI 541 
proteoliposomes were diluted into K+ buffer at pH 8.0 containing 5 nM valinomycin (val) and 542 
the indicated concentrations of [14C]-cadaverine. The initial rates of fluorescence change are 543 
plotted relative to the concentration of cadaverine, corrected for the small level of 544 
fluorescence change observed in liposomes containing no protein. From a Michaelis-Menten 545 
curve fitted to the data points an apparent Km of 2.65±0.52 mM was derived. (C) 546 
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(Proteo)liposomes were diluted into K+ buffer at pH 8.0, 1 mM cadaverine was added at the 547 
first arrow and 5 nM valinomycin was added at the second arrow. (D) (Proteo)liposomes were 548 
diluted into K+ buffer at pH 7.0, 5 nM valinomycin was added at the first arrow and 100 mM 549 
cadaverine was added at the second arrow. The experiments were performed using at least 550 
three independent batches of (proteo)liposomes and error bars show the standard deviations. 551 
 552 
